Chembio Diagnostics Market Cap 2006-2020 | CEMI

Chembio Diagnostics market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Chembio Diagnostics market cap as of September 23, 2020 is $0.09B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.094B $0.034B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $185.552B 34.82
Medtronic (MDT) Ireland $140.269B 26.42
Stryker (SYK) United States $76.229B 29.56
Boston Scientific (BSX) United States $55.224B 31.90
Lonza Group Ag (LZAGY) Switzerland $46.431B 0.00
Baxter (BAX) United States $40.018B 24.47
Terumo (TRUMY) Japan $30.631B 39.15
Zimmer Biomet Holdings (ZBH) United States $28.066B 23.29
EssilorLuxottica Societe Anonyme (ESLOY) France $27.465B 0.00
ResMed (RMD) United States $24.961B 36.19
Sunny Optical Technology (SNPTF) China $17.659B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.515B 0.00
Bio-Rad Laboratories (BIO) United States $15.305B 69.22
Insulet (PODD) United States $15.136B 640.44
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
DiaSorin S.p.A (DSRLF) Italy $10.350B 0.00
GN STORE NORD (GNNDY) Denmark $10.221B 52.10
Quidel (QDEL) United States $8.347B 44.22
William Demant Holdings (WILYY) Denmark $7.100B 0.00
Perrigo (PRGO) Ireland $6.353B 10.90
Canopy Growth (CGC) Canada $5.964B 0.00
Hill-Rom Holdings (HRC) United States $5.488B 13.62
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.462B 0.00
Haemonetics (HAE) United States $4.284B 28.55
Neogen (NEOG) United States $4.165B 68.30
ICU Medical (ICUI) United States $3.965B 30.25
Envista Holdings (NVST) United States $3.774B 25.74
TG Therapeutics (TGTX) United States $3.247B 0.00
National Vision Holdings (EYE) United States $3.145B 488.88
GW Pharmaceuticals (GWPH) United Kingdom $3.136B 0.00
Abcam (ABCZY) $2.987B 0.00
NuVasive (NUVA) United States $2.615B 36.45
Agios Pharmaceuticals (AGIO) United States $2.529B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.824B 166.38
AtriCure (ATRC) United States $1.754B 0.00
NanoString Technologies (NSTG) United States $1.739B 0.00
Cardiovascular Systems (CSII) United States $1.396B 0.00
MacroGenics (MGNX) United States $1.396B 0.00
Aphria (APHA) Canada $1.308B 0.00
InMode (INMD) Israel $1.128B 28.44
Cerus (CERS) United States $1.037B 0.00
Quanterix (QTRX) United States $0.946B 0.00
Owens & Minor (OMI) United States $0.912B 20.43
BioLife Solutions (BLFS) United States $0.863B 449.67
OraSure Technologies (OSUR) United States $0.853B 0.00
Aurora Cannabis (ACB) Canada $0.845B 0.00
Lantheus Holdings (LNTH) United States $0.831B 11.52
PetIQ (PETQ) United States $0.830B 23.80
Meridian Bioscience (VIVO) United States $0.737B 17.01
Phibro Animal Health (PAHC) United States $0.710B 16.24
Vapotherm (VAPO) United States $0.680B 0.00
LeMaitre Vascular (LMAT) United States $0.657B 40.12
Omeros (OMER) United States $0.599B 0.00
Zynex (ZYXI) United States $0.596B 52.06
Eagle Pharmaceuticals (EGRX) United States $0.542B 76.54
Surmodics (SRDX) United States $0.523B 57.40
VAREX IMAGING (VREX) United States $0.470B 20.37
Cytosorbents (CTSO) United States $0.353B 0.00
HEXO (HEXO) $0.345B 0.00
Viemed Healthcare (VMD) United States $0.342B 12.24
Utah Medical Products (UTMD) United States $0.286B 24.53
Neptune Wellness Solutions (NEPT) Canada $0.267B 0.00
InfuSystems Holdings (INFU) United States $0.262B 49.88
Surface Oncology (SURF) United States $0.257B 0.00
Organigram Holdings (OGI) Canada $0.231B 0.00
Female Health (VERU) United States $0.189B 0.00
Chimerix (CMRX) United States $0.177B 0.00
Wound Management Technologies (SMTI) United States $0.163B 0.00
Fonar (FONR) United States $0.154B 13.68
Bovie Medical (APYX) United States $0.153B 0.00
Exagen (XGN) United States $0.140B 0.00
Liberty Health Sciences (LHSIF) United States $0.134B 0.00
Evolus (EOLS) United States $0.128B 0.00
Rockwell Medical (RMTI) United States $0.118B 0.00
Capricor Therapeutics (CAPR) United States $0.105B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.46
Brainsway (BWAY) Israel $0.063B 0.00
MTech Acquisition (KERN) United States $0.057B 0.00
Nephros (NEPH) United States $0.054B 0.00
Trinity Biotech (TRIB) Ireland $0.052B 9.82
ImmuCell (ICCC) United States $0.038B 0.00
FSD PHARMA INC (HUGE) Canada $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.021B 0.00
GUARDION HEALTH (GHSI) United States $0.020B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.019B 0.00
NF Energy Saving (BIMI) China $0.018B 0.00
Myomo (MYO) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00